Aurobindo Pharma Limited — Escitalopram Exporter Profile
Indian Pharmaceutical Exporter · #5 for Escitalopram · $33.4M export value · DGFT Verified
Aurobindo Pharma Limited is the #5 Indian exporter of Escitalopram with $33.4M in export value and 218 verified shipments. Aurobindo Pharma Limited holds a 11.5% market share in Escitalopram exports across 11 countries. The company exports 81 pharmaceutical products worth $1.1B across 18 therapeutic categories.
Aurobindo Pharma Limited — Escitalopram Export Profile: Buyers & Destinations
Where Does Aurobindo Pharma Limited Export Escitalopram?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $10.0M | 253 | 51.8% |
| MALTA | $2.3M | 277 | 11.9% |
| FINLAND | $1.9M | 84 | 9.9% |
| FRANCE | $1.3M | 52 | 6.6% |
| CANADA | $1.1M | 43 | 5.7% |
| GREECE | $452.2K | 22 | 2.3% |
| UNITED KINGDOM | $415.3K | 13 | 2.1% |
| COLOMBIA | $370.5K | 12 | 1.9% |
| UNITED STATES OF AMERICA | $341.9K | 8 | 1.8% |
| SOUTH AFRICA | $292.7K | 13 | 1.5% |
Aurobindo Pharma Limited exports Escitalopram to 23 countries. The largest destination is UNITED STATES accounting for 51.8% of Aurobindo Pharma Limited's Escitalopram shipments, followed by MALTA (11.9%) and FINLAND (9.9%). These destinations reflect Aurobindo Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Escitalopram from Aurobindo Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AUROLOGISTICS LLC (AUROBINDO PHARMA | UNITED STATES | $2.3M | 57 |
| AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $1.6M | 35 |
| AUROLOGISTICS LLC | UNITED STATES | $1.5M | 34 |
| ORION CORPORATION | FINLAND | $1.3M | 56 |
| AUROLOGISTICS LLC AUROBINDO PHARM | UNITED STATES | $1.3M | 28 |
| APL SWIFT SERVICES (MALTA) LTD., | MALTA | $1.1M | 131 |
| ARROW GENERIQUES, | FRANCE | $940.1K | 40 |
| AUROLOGISTICS LLC(AUROBINDO PHARMA | UNITED STATES | $886.6K | 21 |
| AURO PHARMA INC, | CANADA | $760.0K | 19 |
| APL SWIFT SERVICES MALTA LTD | MALTA | $704.5K | 54 |
Aurobindo Pharma Limited supplies Escitalopram to 75 buyers globally. The largest buyer is AUROLOGISTICS LLC (AUROBINDO PHARMA (UNITED STATES), followed by AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES) and AUROLOGISTICS LLC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Escitalopram Export Value and How Much Does Aurobindo Pharma Limited Contribute?
India exported $109.7M worth of Escitalopram through 5,457 shipments from 231 suppliers to 95 countries, serving 628 buyers globally. Aurobindo Pharma Limited contributes $33.4M to this total, accounting for 11.5% of India's Escitalopram exports. Aurobindo Pharma Limited ships Escitalopram to 23 countries through 75 buyers.
What Is the Average Shipment Value for Aurobindo Pharma Limited's Escitalopram Exports?
Aurobindo Pharma Limited's average Escitalopram shipment value is $153.4K per consignment, based on 218 shipments totaling $33.4M. The largest destination is UNITED STATES (51.8% of Aurobindo Pharma Limited's Escitalopram exports).
How Does Aurobindo Pharma Limited Compare to Other Indian Escitalopram Exporters?
Aurobindo Pharma Limited ranks #5 among 231 Indian Escitalopram exporters with a 11.5% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($22.5M), SANDOZ PRIVATE LIMITED ($12.9M), TORRENT PHARMACEUTICALS LTD ($12.1M). Aurobindo Pharma Limited processed 218 shipments to 11 destination countries.
What Escitalopram Formulations Does Aurobindo Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ESCITALOPRAM 20 MG TABLETS (ESCITALOPRAM | $807.6K | 17 |
| ESCITALOPRAM 20 MG TABLETS (ESCITALOPRAMTABLETS USP 20 MG) 500'S | $400.0K | 8 |
| ESCITALOPRAM TABLETS USP 10MG (Escitalop | $365.4K | 11 |
| ESCITALOPRAM TABLETS USP 10MG (ESCITALOPRAM TABLETS USP 10 MG) 500'S | $350.0K | 7 |
| ESCITALOPRAM 20 MG TABLETS(ESCITALOPRAM | $327.6K | 21 |
| ESCITALOPRAM 20 MG TABLETS(Escitalopram | $300.8K | 9 |
| ESCITALOPRAM TABLETS USP 10MG (ESCITALOP | $300.0K | 6 |
| ESCITALOPRAM 5 MG TABLETS (53856X100'S) | $300.0K | 6 |
| ESCITALOPRAM 20 MG TABLETS (Escitalopram | $292.8K | 28 |
| ESCITALOPRAM 20 MG TABLETS (ESCITALOPRAMTABLETS USP 20 MG) 500'SNOS | $256.1K | 6 |
Aurobindo Pharma Limited exports 467 distinct Escitalopram formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ESCITALOPRAM 20 MG TABLETS (ESCITALOPRAM with 17 shipments worth $807.6K.
Regulatory Requirements: Exporting Escitalopram to Key Markets
What Aurobindo Pharma Limited must comply with to export Escitalopram to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Aurobindo Pharma Limited Compare to Nearest Escitalopram Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | SANDOZ PRIVATE LIMITED | $12.9M | 281 | 9 | $46.1K |
| 3 | TORRENT PHARMACEUTICALS LTD | $12.1M | 242 | 14 | $50.0K |
| 5 | AUROBINDO PHARMA LIMITED ★ | $10.9M | 218 | 11 | $50.0K |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $10.7M | 293 | 11 | $36.6K |
| 7 | CIPLA LIMITED | $7.9M | 218 | 7 | $36.1K |
Aurobindo Pharma Limited ranks #5 among 231 Indian Escitalopram exporters. Average shipment value of $50.0K compared to the market average of $474.7K. The closest competitors by value are SANDOZ PRIVATE LIMITED and TORRENT PHARMACEUTICALS LTD.
Which Indian Ports Ship Escitalopram Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 652 | 11.9% |
| SAHAR AIR | 555 | 10.2% |
| NHAVA SHEVA SEA (INNSA1) | 471 | 8.6% |
| HYDERABAD ICD | 369 | 6.8% |
| DELHI AIR CARGO ACC (INDEL4) | 303 | 5.6% |
| DELHI AIR | 287 | 5.3% |
| HYDERABAD ICD (INSNF6) | 243 | 4.5% |
| HYDERABAD AIR | 217 | 4.0% |
What Other CNS & Psychiatric Products Does Aurobindo Pharma Limited Export?
Aurobindo Pharma Limited also exports these cns & psychiatric products. Each links to the detailed product page.
About Aurobindo Pharma Limited
Aurobindo Pharma Limited exports 81 products worth $1.1B. Beyond Escitalopram, top products include Amoxicillin, Potassium, Pantoprazole, Clopidogrel, Rosuvastatin. View the complete Aurobindo Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Escitalopram — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Escitalopram shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aurobindo Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 823 individual customs records matching Aurobindo Pharma Limited exporting Escitalopram, covering 467 formulations to 23 countries via 75 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 95+ countries, 628+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Escitalopram Export Data from Aurobindo Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Limited's Escitalopram exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Limited
Full Company Profile →
81 products · $1.1B total trade · 18 categories
Escitalopram Stats
Company Overview
Top Products by Aurobindo Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Escitalopram. For current shipment-level data, contact TransData Nexus.